http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007134157-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4121357d3c63c901530b5c42e7ffc019 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
filingDate | 2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0d6993792e8a4bed46549ffbfe7884e |
publicationDate | 2007-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2007134157-A1 |
titleOfInvention | Biological assay |
abstract | The invention is a method for determining an in vivo cardiac electrophysiology profile of a compound affecting one or more cardiac ion channels which comprises administering the compound to a rat, and simultaneously measuring one or more periods selected from the group consisting of an atrial refractory period, a ventricular refractory period, and an AV nodal refractory period, and one or more intervals selected from an electrocardiogram interval and a cardiac electrogram conduction interval. |
priorityDate | 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.